Images List Premium Download Classic

Skin Diseases

Skin Diseases-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Therapeutic or prophylactic agent for itching skin diseases
Toray Industries, Inc.
October 05, 2017 - N°20170281727

An antimicrobial peptide ll-37 has an action to promote expression of a nerve repulsion factor sema3a. Ll-37 is a peptide composed of the c-terminal 37 residues of human cathelicidin hcap18. Use of this antimicrobial peptide enables normalization of expression of axon guidance molecules such as nerve repulsion factor in lesions of pruritic dermatoses including atopic dermatitis and xeroderma, and thus ...
Benzoxazinone derivatives for treatment of skin diseases
Sixera Pharma Ab
September 21, 2017 - N°20170267692

The present invention relates to methods and compositions for inhibiting the activity of skin proteases, especially human kallikrein 7 (klk7), human kallikrein 5 (klk5), and human kallikrein 14 (klk14). More specifically, the invention relates to the use of substituted 3,1-benzoxazin-4-ones being selective inhibitors of human skin kallikreins for the treatment of skin diseases, more specifically for the treatment of inflammatory skins diseases, ...
Topical formulations comprising a steroid
Dr. Reddy's Laboratories Ltd.
September 14, 2017 - N°20170258813

The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are propellant-free, and/or substantially non-foaming, and/or alcohol-free. The present application also provides processes for preparing such compositions and methods of using them in management of skin diseases or disorders such as psoriasis, dermatoses, and ...
Skin Diseases Patent Pack
Download + patent application PDFs
Skin Diseases Patent Applications
Download + Skin Diseases-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Skin Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity
Bioniz, Llc
July 20, 2017 - N°20170204153

The γc-family cytokines, interleukin-2 (il-2), interleukin-4 (il-4), interleukin-7 (il-7), interleukin-9 (il-9), interleukin-15 (il-15), and interleukin-21 (il-21), are associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (gvhd). Thus, inhibitors of γc-cytokine activity are valuable therapeutic and cosmetic agents as well as research tools. ...
Composition comprising gpcr19 agonist as an active ingredient for preventing or treating allergic dermatitis
Shaperon Inc.
July 13, 2017 - N°20170196895

The present invention is about a pharmaceutical composition, an oral preparation, and an injection preparation containing a g protein-coupled receptor19 (gpcr19) agonist, specifically sodium taurodeoxycholate(hy2191) and its derivative, as an active ingredient for preventing or treating allergic skin diseases. The present invention is also about an external preparation and a cosmetic composition containing said pharmaceutical composition for preventing and ...
Methods of preparing materials with ammonia oxidizing bacteria and testing materials for ammonia oxidizing bacteria
Aobiome Llc
July 06, 2017 - N°20170191109

This disclosure provides, inter alia, systems and methods for testing products for ammonia oxidizing bacteria, quality control, and providing products with ammonia oxidizing bacteria. The systems and methods herein may be used, inter alia, to treat diseases associated with low nitrite levels, skin diseases, and diseases caused by pathogenic bacteria.
Skin Diseases Patent Pack
Download + patent application PDFs
Skin Diseases Patent Applications
Download + Skin Diseases-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Skin Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
Allergan, Inc.
June 29, 2017 - N°20170182028

The present invention relates to a method for treating skin diseases and skin conditions in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline, or its individual enantiomers or the tautomers thereof, or a pharmaceutically acceptable salt thereof.
Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof
Imprimis Pharmaceuticals, Inc.
June 15, 2017 - N°20170165280

Pharmaceutical compositions for treating, mitigating or preventing inflammatory skin diseases, disorders and/or pathologies are described, the compositions comprising a tetracycline-class antibiotic(s), omega fatty acid(s), and/or nicotinic acid or derivatives thereof. Methods for fabricating the compositions and using them are also described.
Corticosteriod containing foam compositions and method of manufacture thereof
Therapeutics Inc.
June 15, 2017 - N°20170165276

The present invention provides a method of manufacturing foamable, corticosteroid containing compositions as well as methods for treating various skin diseases.
Halobetasol foam composition and method of use thereof
Therapeutics Inc.
June 15, 2017 - N°20170165275

The present invention provides a composition and method for treating various skin diseases. The composition is formulated as a foamable composition and includes the corticosteroid halobetasol.
Complexes of sirolimus and its derivatives, process for the preparation thereof and pharmaceutical compositions containing ...
Druggability Technologies Ip Holdco Limited
June 15, 2017 - N°20170165237

The invention is directed to a stable complex with controlled particle size, increased apparent solubility and increased dissolution rate comprising as active compound sirolimus or derivatives thereof, which is useful in the prophylaxis of organ rejection in patients receiving renal transplants, in the treatment of psoriasis, facial angiofibromas associated with tuberous sclerosis, fibrofolliculomas found in birt-hogg-dubé syndrome, chronic erosive ...
Probiotic treatment of skin diseases, disorders, and infections: formulations, methods and systems
Druggability Technologies Ip Holdco Limited
May 25, 2017 - N°20170143621

The present invention teaches compositions, methods and kits for treating skin conditions, including dandruff. In various embodiments, the compositions include an effective amount of one or more probiotic microorganism of vaginal origin and/or a fraction thereof and/or a component of the metabolome for preventing and/or treating skin disorders of the scalp.
Antibodies against human sodium channel nav1.9 and uses thereof for the diagnosis of inflammatory skin ...
Universite D'aix-marseille
May 11, 2017 - N°20170131292

Antibodies against the human sodium channel nav 1. 9 are described. Also described, is the use of such antibodies in the diagnosis of inflammatory skin diseases. A process for preparing antibodies directed against the human nav 1. 9 is also described.
Skin Diseases Patent Pack
Download + patent application PDFs
Skin Diseases Patent Applications
Download + Skin Diseases-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Skin Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions and methods for treatment of inflammatory skin conditions using allantoin
Scioderm, Inc.
April 20, 2017 - N°20170105968

Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0. 5% to about 15. 0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis ...
Compositions and methods of treatment of inflammatory skin conditions using allantoin
Scioderm, Inc.
April 20, 2017 - N°20170105967

Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0. 5% to about 15. 0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis ...
Modulating gamma-c-cytokine activity
Bioniz, Llc
April 13, 2017 - N°20170101452

Embodiments relate to peptide antagonists of γc-family cytokines, which is associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (gvhd). Thus, inhibitors of γc-cytokine activity are valuable therapeutic and cosmetic agents as well as research tools. Traditional approaches to inhibiting γc-cytokine ...
Novel tricyclic modulators of cannabinoid receptors
The University Of Montana
April 06, 2017 - N°20170096426

The compounds of the invention are modulators of cannabinoid receptors cb1 or cb2. The compounds can be used for the prevention or treatment of, e. G., pain, cancer, skin diseases, weight-associated disorders, chemical addictions, psychiatric disorders, neurodegenerative disorders, bone diseases, and inflammatory diseases. The compounds of the invention can further be used to study these diseases and disorders, as well ...
Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
Allergan,inc.
April 06, 2017 - N°20170095466

The present invention relates to a method for treating skin diseases and skin conditions in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline, or its individual enantiomers or the tautomers thereof, or a pharmaceutically acceptable salt thereof.
Use of coumarin derivatives for the preparation of drugs for treating skin diseases
Allergan,inc.
March 09, 2017 - N°20170065555

Wherein n equals 0 or 1, z represents o or s, r1 represents one group chosen among the group consisting of hydrogen, c1-c7 alkyl, substituted, or not, by a halogen, a hydroxyl or a —o—r12 group, wherein r12 is a c1-c7 alkyl, a group —ch2—o—co—r5 wherein r5 is chosen among ...
Ammonia-oxidizing nitrosomonas eutropha strain d23
Aobiome Llc
February 09, 2017 - N°20170037363

This disclosure provides, inter alia, an optimized strain of nitrosomonas eutropha (n. Eutropha) designated d23, d23-100, or aob d23-100. N. Eutropha bacteria disclosed in this application have desirable properties, e. G., optimized properties, such as the ability to suppress growth of pathogenic bacteria, and an enhanced ability to produce nitric oxide and nitric oxide precursors. The n. Eutropha ...
Novel pseudo ceramide compound, and pharmaceutical composition and cosmetic composition comprising same
Neopharm Co., Ltd.
February 09, 2017 - N°20170036995

The present invention relates to a pharmaceutical composition and a cosmetic composition, which contain, as an active ingredient, a novel pseudo compound having similar structural characteristics to natural ceramide 1, or a pharmaceutically acceptable salt or solvate thereof, and the composition containing the compound of the present invention as an active ingredient has an excellent effect of enhancing a skin barrier ...
Loading